NCT02707536

Brief Summary

The goal of this project is to evaluate the influence of platelet rich fibrin (PRF) in extraction socket healing with or without particulate bone graft. The hypothesis of this study is that PRF will enhance the extraction socket healing and new bone formation when compared to extraction sockets grafted without PRF.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

March 9, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 14, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

May 4, 2017

Status Verified

May 1, 2017

Enrollment Period

1.8 years

First QC Date

March 9, 2016

Last Update Submit

May 2, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in alveolar ridge width (buccal-lingual)

    Baseline is at the time of extraction with or without socket grafting.

    baseline, 3 months

  • Change in alveolar ridge height (apical coronal)

    Baseline is at the time of extraction with or without socket grafting.

    baseline, 3 months

Secondary Outcomes (2)

  • Percentage of vital bone in bone core as assessed histology

    3 months

  • Percentage of residual bone graft in bone core as assessed histology

    3 months

Study Arms (4)

No socket grafting

NO INTERVENTION

Extraction with normal socket healing

Socket grafting with platelet rich fibrin (PRF) alone

ACTIVE COMPARATOR

Extraction with socket grafting with platelet rich fibrin (PRF) alone.

Procedure: Socket grafting with PRF

Socket grafting with bone grafting alone

ACTIVE COMPARATOR

Extraction with socket grafting using bone graft (xenograft).

Procedure: Socket grafting with bone graft

Socket grafting with PRF and bone grafting

ACTIVE COMPARATOR

Extraction with socket grafting using PRF combined with bone graft (xenograft).

Procedure: Socket grafting with PRFProcedure: Socket grafting with bone graft

Interventions

Extraction with socket grafting using PRF.

Socket grafting with PRF and bone graftingSocket grafting with platelet rich fibrin (PRF) alone

Extraction with socket grafting using bone graft.

Socket grafting with PRF and bone graftingSocket grafting with bone grafting alone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects ≥ 18 years of age
  • Hopeless or non-restorable single non-molar tooth per quadrant with adjacent teeth present
  • Maximum of two teeth can qualify per patient.
  • The buccal plate must be ≥ 1mm in width with a 4-wall configuration.
  • Cases requiring minimal sinus grafting (\<3mm)
  • Bone grafting limited to the apical portion of the osteotomy site

You may not qualify if:

  • Untreated periodontal disease, endodontic-periodontal disease and/or caries
  • The buccal plate must be ≤ 3mm in width with a 4-wall configuration.
  • Patients with uncontrolled or severe systemic disease (Diabetes)
  • Patients with medical conditions or taking medication associated with compromised bone healing (Diabetes, Autoimmune Dysfunction, Prolonged Cortisone Therapy, Chemotherapy, or Bisphosphonate Therapy)
  • Current Smokers
  • Subjects with extensive parafunctional habits (ie; bruxism)
  • Subjects who demonstrate inadequate oral hygiene

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston School of Dentistry

Houston, Texas, 77030, United States

Location

MeSH Terms

Interventions

Prolactin-Releasing HormoneBone Transplantation

Intervention Hierarchy (Ancestors)

Hypothalamic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsNeuropeptidesPeptidesAmino Acids, Peptides, and ProteinsNerve Tissue ProteinsProteinsTissue TransplantationCell- and Tissue-Based TherapyBiological TherapyTherapeuticsOrthopedic ProceduresSurgical Procedures, OperativeTransplantation

Study Officials

  • Sridhar Eswaran, BDS, MS, MSD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 9, 2016

First Posted

March 14, 2016

Study Start

May 1, 2014

Primary Completion

March 1, 2016

Study Completion

May 1, 2016

Last Updated

May 4, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share

Locations